Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP374017.RAwjKVGzjLKJ9X7lqM7j-UtLG7xTHzDL2ZoDIt4Rt6BUc130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374017.RAwjKVGzjLKJ9X7lqM7j-UtLG7xTHzDL2ZoDIt4Rt6BUc130_provenance.
• NP894500.RA7F1ziK43rE8IK9W-tb8qGbCceNJkEIXuXL5MVXYcND0130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894500.RA7F1ziK43rE8IK9W-tb8qGbCceNJkEIXuXL5MVXYcND0130_provenance.
• NP865625.RAckix8TIDbSIOWVsFLN7OgNCWXDC_iTH41-xxTiYfMt4130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865625.RAckix8TIDbSIOWVsFLN7OgNCWXDC_iTH41-xxTiYfMt4130_provenance.
• assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715140.RAac5JKBLSQjr4KODV1UKTjf18pEUWp47-svPyOwAp86w130_provenance.
• NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_assertion description "[Herein, we show that in vivo administration of all-trans-retinoic acid (ATRA) or the histone deacetylase inhibitor sodium valproate (VPA) to patients affected with acute myeloid leukaemia (AML) M3 or M1 respectively, leads to the induction of transcription and expression of NKG2D-L at the surface of leukaemic cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015518.RAt8mVO6CGTaKwuJd4qEzLSvRHHDcgNaLJZQ2tzMoaMFA130_provenance.